176 related articles for article (PubMed ID: 34952929)
1. Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients.
Bethge WA; Eyrich M; Mielke S; Meisel R; Niederwieser D; Schlegel PG; Schulz A; Greil J; Bunjes D; Brecht A; Kuball J; Schumm M; Vucinic V; Wiesneth M; Bonig H; Westinga K; Biedermann S; Holtkamp S; Karitzky S; Malchow M; Siewert C; Handgretinger R; Lang P
Bone Marrow Transplant; 2022 Mar; 57(3):423-430. PubMed ID: 34952929
[TBL] [Abstract][Full Text] [Related]
2. Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia.
Merli P; Algeri M; Galaverna F; Milano GM; Bertaina V; Biagini S; Girolami E; Palumbo G; Sinibaldi M; Becilli M; Leone G; Boccieri E; Grapulin L; Gaspari S; Airoldi I; Strocchio L; Pagliara D; Locatelli F
Front Immunol; 2020; 11():699. PubMed ID: 32477328
[TBL] [Abstract][Full Text] [Related]
3. TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients.
Kaynar L; Demir K; Turak EE; Öztürk ÇP; Zararsız G; Gönen ZB; Gökahmetoğlu S; Şıvgın S; Eser B; Köker Y; Solmaz M; Ünal A; Çetin M
Hematology; 2017 Apr; 22(3):136-144. PubMed ID: 27724812
[TBL] [Abstract][Full Text] [Related]
4. T-cell receptor αβ
Shah RM; Elfeky R; Nademi Z; Qasim W; Amrolia P; Chiesa R; Rao K; Lucchini G; Silva JMF; Worth A; Barge D; Ryan D; Conn J; Cant AJ; Skinner R; Abd Hamid IJ; Flood T; Abinun M; Hambleton S; Gennery AR; Veys P; Slatter M
J Allergy Clin Immunol; 2018 Apr; 141(4):1417-1426.e1. PubMed ID: 28780238
[TBL] [Abstract][Full Text] [Related]
5. Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency Syndromes.
Balashov D; Shcherbina A; Maschan M; Trakhtman P; Skvortsova Y; Shelikhova L; Laberko A; Livshits A; Novichkova G; Maschan A
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1955-62. PubMed ID: 26187864
[TBL] [Abstract][Full Text] [Related]
6. CD3
Ramanathan S; Lum SH; Nademi Z; Carruthers K; Watson H; Flood T; Owens S; Williams E; Hambleton S; Gennery AR; Slatter M
Transplant Cell Ther; 2023 Aug; 29(8):513.e1-513.e9. PubMed ID: 37279857
[TBL] [Abstract][Full Text] [Related]
7. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study.
Federmann B; Bornhauser M; Meisner C; Kordelas L; Beelen DW; Stuhler G; Stelljes M; Schwerdtfeger R; Christopeit M; Behre G; Faul C; Vogel W; Schumm M; Handgretinger R; Kanz L; Bethge WA
Haematologica; 2012 Oct; 97(10):1523-31. PubMed ID: 22491731
[TBL] [Abstract][Full Text] [Related]
8. αβ T Cell-Depleted Haploidentical Hematopoietic Stem Cell Transplantation without Antithymocyte Globulin in Children with Chemorefractory Acute Myelogenous Leukemia.
Shelikhova L; Ilushina M; Shekhovtsova Z; Shasheleva D; Khismatullina R; Kurnikova E; Pershin D; Balashov D; Radygina S; Trakhtman P; Kalinina I; Muzalevskii Y; Kazachenok A; Zaharova V; Brilliantova V; Olshanskaya Y; Panferova A; Zerkalenkova E; Baidildina D; Novichkova G; Rumyantsev A; Maschan A; Maschan M
Biol Blood Marrow Transplant; 2019 May; 25(5):e179-e182. PubMed ID: 30677509
[TBL] [Abstract][Full Text] [Related]
9. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L
Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547
[TBL] [Abstract][Full Text] [Related]
10. Haploidentical HSCT for hemoglobinopathies: improved outcomes with TCRαβ
Gaziev J; Isgrò A; Sodani P; Paciaroni K; De Angelis G; Marziali M; Ribersani M; Alfieri C; Lanti A; Galluccio T; Adorno G; Andreani M
Blood Adv; 2018 Feb; 2(3):263-270. PubMed ID: 29431621
[TBL] [Abstract][Full Text] [Related]
11. A Conditioning Regimen with Plerixafor Is Safe and Improves the Outcome of TCRαβ
Balashov D; Laberko A; Shcherbina A; Trakhtman P; Abramov D; Gutovskaya E; Kozlovskaya S; Shelikhova L; Novichkova G; Maschan M; Rumiantsev A; Maschan A
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1432-1440. PubMed ID: 29550630
[TBL] [Abstract][Full Text] [Related]
12. Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric Patients.
Arnold DE; MacMath D; Seif AE; Heimall JR; Wang Y; Monos D; Grupp SA; Bunin NJ
Transplant Cell Ther; 2021 Feb; 27(2):169.e1-169.e9. PubMed ID: 33830028
[TBL] [Abstract][Full Text] [Related]
13. Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity.
Bethge WA; Haegele M; Faul C; Lang P; Schumm M; Bornhauser M; Handgretinger R; Kanz L
Exp Hematol; 2006 Dec; 34(12):1746-52. PubMed ID: 17157172
[TBL] [Abstract][Full Text] [Related]
14. Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia.
Lang P; Teltschik HM; Feuchtinger T; Müller I; Pfeiffer M; Schumm M; Ebinger M; Schwarze CP; Gruhn B; Schrauder A; Albert MH; Greil J; Urban C; Handgretinger R
Br J Haematol; 2014 Jun; 165(5):688-98. PubMed ID: 24588540
[TBL] [Abstract][Full Text] [Related]
15. Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patients.
Lang P; Feuchtinger T; Teltschik HM; Schwinger W; Schlegel P; Pfeiffer M; Schumm M; Lang AM; Lang B; Schwarze CP; Ebinger M; Urban C; Handgretinger R
Bone Marrow Transplant; 2015 Jun; 50 Suppl 2():S6-10. PubMed ID: 26039210
[TBL] [Abstract][Full Text] [Related]
16. Co-transplantation of mesenchymal stromal cell and haploidentical hematopoietic stem cell with TCR αβ depletion in children with primary immunodeficiency syndromes.
Atay D; Akcay A; Akinci B; Yenigurbuz FD; Ovali E; Ozturk G
Pediatr Transplant; 2021 Dec; 25(8):e14120. PubMed ID: 34409718
[TBL] [Abstract][Full Text] [Related]
17. Unrelated donor α/β T cell- and B cell-depleted HSCT for the treatment of pediatric acute leukemia.
Leahy AB; Li Y; Talano JA; Elgarten CW; Seif AE; Wang Y; Johnson B; Monos DS; Kadauke S; Olson TS; Freedman J; Wray L; Grupp SA; Bunin N
Blood Adv; 2022 Feb; 6(4):1175-1185. PubMed ID: 34872106
[TBL] [Abstract][Full Text] [Related]
18. TCRαβ/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis.
Merli P; Algeri M; Galaverna F; Bertaina V; Lucarelli B; Boccieri E; Becilli M; Quagliarella F; Rosignoli C; Biagini S; Girolami E; Meschini A; Del Principe G; Sborgia R; Catanoso ML; Carta R; Strocchio L; Pinto RM; Buldini B; Falco M; Meazza R; Pende D; Andreani M; Li Pira G; Pagliara D; Locatelli F
Blood; 2024 Jan; 143(3):279-289. PubMed ID: 37738655
[TBL] [Abstract][Full Text] [Related]
19. TCR-alpha/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia.
Maschan M; Shelikhova L; Ilushina M; Kurnikova E; Boyakova E; Balashov D; Persiantseva M; Skvortsova Y; Laberko A; Muzalevskii Y; Kazachenok A; Glushkova S; Bobrynina V; Kalinina V; Olshanskaya Y; Baidildina D; Novichkova G; Maschan A
Bone Marrow Transplant; 2016 May; 51(5):668-74. PubMed ID: 26808573
[TBL] [Abstract][Full Text] [Related]
20. αβ
Dadi G; Jacoby E; Adam E; Hutt D; Varda-Bloom N; Bielorai B; Toren A
Pediatr Transplant; 2023 Aug; 27(5):e14531. PubMed ID: 37127942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]